JY
ENTL

Jeff Yass’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Jeff Yass’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,200
Closed -$207K – 10342
2017
Q3 		$207K Buy
+11,200
New +$194K ﹤0.01% 7968

Other funds holding ENTL

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $383M AUM 123.08% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Jeff Yass's ENTL Position: Q1 2017 in Review

Jeff Yass sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2017, closing a stake of 11,775 shares — an estimated $223K sold.

Jeff Yass first reported a position in ENTL in Q1 2015 and held it in 2 quarters. The position peaked at $286K in Q1 2015. 69 funds tracked by Wall St. Rank hold ENTL as of Q1 2017.

  • Jeff Yass reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Jeff Yass sold 11,775 Entellus Medical, Inc. Common Stock shares in Q1 2017, an estimated $223K.
  • Jeff Yass first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
  • Jeff Yass's Entellus Medical, Inc. Common Stock position peaked at $286K in Q1 2015.
  • 69 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.